AC
VIVS

Armistice Capital’s VivoSim Labs VIVS Stock Holding History

Armistice Capital’s Portfolio VIVS Stock Details VIVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-136,554
Closed -$754K – 287
2024
Q4 		$754K Buy
136,554
+35,054
+35% +$178K 0.01% 172
2024
Q3 		$620K Buy
101,500
+24,083
+31% +$168K 0.01% 184
2024
Q2 		$708K Buy
+77,417
New +$914K 0.01% 169

Other funds holding VIVS

PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
AFG
Albion Financial Group Salt Lake City, Utah $1.55B AUM 19.86% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Armistice Capital's VIVS Position: Q1 2025 in Review

Armistice Capital sold out of VivoSim Labs (VIVS) in Q1 2025, closing a stake of 136,554 shares — an estimated $754K sold.

Armistice Capital first reported a position in VIVS in Q2 2024 and held it in 3 quarters. The position peaked at $754K in Q4 2024. 23 funds tracked by Wall St. Rank hold VIVS as of Q1 2025.

  • Armistice Capital reported no remaining VivoSim Labs position as of Q1 2025 after selling out during the quarter.
  • Armistice Capital sold 136,554 VivoSim Labs shares in Q1 2025, an estimated $754K.
  • Armistice Capital first reported a position in VivoSim Labs in Q2 2024 and held it in 3 quarters.
  • Armistice Capital's VivoSim Labs position peaked at $754K in Q4 2024.
  • 23 funds tracked by Wall St. Rank held VivoSim Labs as of Q1 2025.

Based on Armistice Capital's 13F filing for Q1 2025, filed 15 May 2025.